-
Notice of Office Closure
GeneDesign, Inc. – Osaka Site
-
Notice of Appointment of Directors
GeneDesign, Inc. – Osaka Site
-
Impact of the Current Situation in the Middle East on Our Manufacturing Operations
GeneDesign, Inc. – Osaka Site
-
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
-
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody–Drug Conjugate Development
-
Notice of Office Closure
GeneDesign, Inc. – Osaka Site
-
Notice of Office Closure
GeneDesign, Inc. – Osaka Site
-
Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards
-
Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology
-
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing
-
Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics
-
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.